PANTHERx® Specialty Pharmacy announced today that it has entered into a partnership with The Health Plan as a provider of specialty pharmacy medications across multiple...

PANTHERx® Specialty Pharmacy announced today that it has expanded its preferred partnership with Highmark to include Crysvita™ (burosumab-twza). Crysvita™ (burosumab-twza) is the first FDA-approved therapy...

Gene therapy isn’t on the horizon anymore; it’s here.  Precision medicine demands a level of personalization that few Specialty Pharmacies are equipped to handle.  PANTHERx®’s...

PANTHERx® Specialty Pharmacy is pleased to announce that it has received full reaccreditation from URAC, pursuant to Specialty Pharmacy, Version 3.0. This accreditation is a...

PANTHERx® Specialty Pharmacy’s Fellowship program was featured in an article published by Specialty Pharmacy Continuum on April 11, 2018. The fellowship is designed to help...

PANTHERx® Specialty Pharmacy is now stocking and dispensing Makena (hydroxyprogesterone caproate injection) subcutaneous auto-injector, a new drug-device combination product.  The new subcutaneous auto-injector offers a...

PANTHERx® Chairman and CEO, Dr. Gordon J. Vanscoy, has been invited to join world business leaders at the 36th annual J.P. Morgan Healthcare Conference, January 8-11, at the...

PANTHERx® Specialty Pharmacy is now stocking and dispensing an oral rinse indicated for the management of oral mucositis/stomatitis that may be caused by radiotherapy and/or...

PANTHERx® Specialty Pharmacy announced today that it has entered into a preferred partnership to provide certain acute care products and supportive services for Highmark members. ...